“…Given that tDCS is a potent placebo-inducing procedure both in the clinical (Aslaksen, Vasylenko, & Fagerlund, 2014) and cognitive domains (Turi, Mittner, Paulus, & Antal, 2017;Turi et al, 2018), there seems to be an urgent need to test alternative active sham protocols (Boonstra, Nikolin, Meisener, Martin, & Loo, 2016;Palm et al, 2013) or develop better active sham protocols to effectively maintain blinding. One possibility may be considering to utilize topical anaesthetic cream to reduce cutaneous sensations (Guarienti et al, 2015;Guleyupoglu, Febles, Minhas, Hahn, & Bikson, 2014;McFadden, Borckardt, George, & Beam, 2011) and vasodilation-induced redness underneath the electrodes (Durand, Fromy, Bouyé, Saumet, & Abraham, 2002;Ezquerro et al, 2017;O'Connell et al, 2012) both of which have previously been identified as potential factors which can break blinding (Guarienti et al, 2015;O'Connell et al, 2012;Palm et al, 2013).…”